Document Detail


Cognitive changes after menopause: influence of estrogen.
MedLine Citation:
PMID:  18677155     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The natural menopause is not associated with substantial cognitive change. Limited clinical trial evidence suggests that estrogen-containing hormone therapy has little effect on cognition during midlife, but prompt initiation after surgical menopause may improve aspects of memory. Among older postmenopausal women, strong clinical trial evidence demonstrates that hormone initiation does not improve cognition. More limited clinical trial evidence indicates no improvement in Alzheimer symptoms, and the Women's Health Initiative Memory Study found an increase in dementia risk among older women. Observational findings of reduced Alzheimer risk may reflect early hormone use in younger women, or findings may be biased. Cognitive effects of selective estrogen receptor modulators are not yet well studied.
Authors:
Victor W Henderson
Related Documents :
18779755 - Prevalence of symptoms in relation to androgen concentrations in women using estrogen p...
19072475 - Estrogen agonists/antagonists in combination with estrogen for prevention and treatment...
10471985 - Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women.
11826265 - Aromatase--a brief overview.
25430485 - Associations of dietary patterns with the risk of all-cause, cvd and stroke mortality: ...
15203825 - Improving obstetrician-gynecologist implementation of smoking cessation guidelines for ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Clinical obstetrics and gynecology     Volume:  51     ISSN:  1532-5520     ISO Abbreviation:  Clin Obstet Gynecol     Publication Date:  2008 Sep 
Date Detail:
Created Date:  2008-08-04     Completed Date:  2008-10-23     Revised Date:  2013-06-05    
Medline Journal Info:
Nlm Unique ID:  0070014     Medline TA:  Clin Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  618-26     Citation Subset:  IM    
Affiliation:
Departmentsof Health Research and Policy (Epidemiology), Stanford University, Stanford, California 94305-5405, USA. vhenderson@stanford.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alzheimer Disease / chemically induced,  epidemiology
Cognition / drug effects*
Cognition Disorders / chemically induced*,  epidemiology
Dementia / chemically induced,  epidemiology
Estrogen Replacement Therapy / adverse effects,  methods*
Estrogens / adverse effects,  therapeutic use
Female
Humans
Menopause / psychology*
Postmenopause
Progestins / adverse effects,  therapeutic use
Grant Support
ID/Acronym/Agency:
R01 AG023038/AG/NIA NIH HHS; R01 AG023038-03/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Estrogens; 0/Progestins
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
Next Document:  Comorbidity in patients undergoing coronary artery bypass graft surgery: impact on outcome and impli...